Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.8 USD | -1.84% | -7.25% | -26.72% |
13/05 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
08/05 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.72% | 20Cr | |
+12.98% | 7.45TCr | |
+11.35% | 918Cr | |
+60.16% | 503.01Cr | |
-12.85% | 502.18Cr | |
+1.60% | 382.03Cr | |
-19.20% | 240.99Cr | |
+18.06% | 239.16Cr | |
-27.46% | 227.4Cr | |
+24.62% | 226.23Cr |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Zevra Therapeutics Resubmits Arimoclomol New Drug Application to FDA